MoneyWorks4Me

Smruthi Organics receives warning letter from USFDA for Solapur plant

18 Mar 2014 Evaluate

Smruthi Organics has received a warning letter from the United States Food & Drugs Administration (USFDA) for its site located at A-27, MIDC Chincholi, Solapur in state of Maharashtra with reference to the observations of inspection performed in October, 2013. The company is working with USFDA in resolving the issues.

Smruthi Organics is a mid-size, public limited, API manufacturing company from Solapur, India. The company has been part of successful contract manufacturing and custom synthesis agreements with leading European, American and Japanese customers.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..